The antimicrobial peptide HNP1, normally part of immune defense, is exploited by Acinetobacter baumannii via its OmpA protein to promote biofilm formation and increase antibiotic resistance.
Host peptide co-opted by pathogenHNP1, an antimicrobial defensin meant to kill bacteria, is instead used by A. baumannii to build protective biofilms via OmpA interaction
What the researchers found
The human antimicrobial peptide HNP1 (human neutrophil α-defensin 1) — normally part of the body's immune defense — paradoxically promotes biofilm formation by the dangerous hospital-acquired pathogen Acinetobacter baumannii. HNP1 was found in the lung fluid of infected patients and interacts with the bacterial outer membrane protein OmpA to enhance biofilm production.
As a result of this HNP1-enhanced biofilm, A. baumannii becomes more tolerant to antibiotics and more effectively colonizes host cells and tissues. This represents a striking example of a pathogen co-opting a host defense peptide for its own benefit.
Why it matters
This finding flips the traditional narrative about defensins as purely protective molecules. It reveals that A. baumannii has evolved to exploit the very immune peptides sent to destroy it, using HNP1 to build biofilms that increase antibiotic resistance. This has implications for understanding treatment failure in hospital-acquired infections and could redirect strategies for combating multidrug-resistant A. baumannii.
How the study worked
Researchers analyzed bronchoalveolar lavage fluids from A. baumannii-infected patients to confirm HNP1 presence. They then conducted in vitro experiments to characterize the interaction between HNP1 and the bacterial outer membrane protein OmpA, and assessed the downstream effects on biofilm formation, antibiotic tolerance, and host cell colonization.
Who was studied
Bronchoalveolar lavage samples from A. baumannii-infected patients; in vitro bacterial culture experiments
What this study cannot tell us
While HNP1 was confirmed present in patient lung fluid, the biofilm formation mechanism was primarily characterized in vitro. The clinical significance of HNP1-promoted biofilm in actual patient outcomes needs further investigation. The study focused on the HNP1-OmpA interaction specifically and may not capture other defensin-bacterial interactions.
How to read the evidence
This is a moderate-grade study published in Nature Communications, combining patient sample analysis with detailed in vitro mechanistic work. The clinical relevance is supported by finding HNP1 in infected patient lung fluid, though the biofilm mechanism is primarily characterized in laboratory conditions.
When this study was published
Published in 2025, this is very recent research that reveals a previously unknown mechanism of pathogen immune evasion with immediate relevance to combating multidrug-resistant hospital infections.
The bigger picture
Acinetobacter baumannii is classified by the WHO as a critical-priority pathogen due to extreme antibiotic resistance. This study reveals a previously unknown mechanism by which the pathogen subverts host immunity — essentially weaponizing our own defense peptides. It's a sobering example of evolutionary arms races and suggests that purely boosting innate immune peptide production may not always help fight infection.
Questions still open
- Could therapies that block the HNP1-OmpA interaction prevent biofilm formation and restore antibiotic sensitivity in A. baumannii infections?
- Do other antimicrobial peptides beyond HNP1 similarly get co-opted by drug-resistant bacteria to promote biofilm?
- Should treatment strategies for A. baumannii pneumonia account for the paradoxical role of neutrophil defensins in worsening infection?
Common questions
How can an antimicrobial peptide actually help bacteria?
Why is Acinetobacter baumannii so dangerous in hospitals?
Read the original research
Human neutrophil α-defensin HNP1 interacts with bacterial OmpA to promote Acinetobacter baumannii biofilm formation.
Nature communications, 16(1), 5629
Citation
Liao, Chongbing; Liu, Qihui; Luo, Gan; Luo, Yinyue; Yao, Dan; Wang, Qingxia; Zhang, Jue; Wu, Yang; Jin, Jialin; Xu, Dan; Lu, Wuyuan. (2025). Human neutrophil α-defensin HNP1 interacts with bacterial OmpA to promote Acinetobacter baumannii biofilm formation.. Nature communications, 16(1), 5629. https://doi.org/10.1038/s41467-025-60935-7